A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Clinical trial NCT04064827 · TERMINATED

Trial details

NCT number: NCT04064827
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)

Start date: 2020-09-16
Primary completion: 2025-06-09
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.